Lijun Yang

506 total citations
25 papers, 350 citations indexed

About

Lijun Yang is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Lijun Yang has authored 25 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in Lijun Yang's work include Bladder and Urothelial Cancer Treatments (3 papers), Prostate Cancer Treatment and Research (3 papers) and Kidney Stones and Urolithiasis Treatments (2 papers). Lijun Yang is often cited by papers focused on Bladder and Urothelial Cancer Treatments (3 papers), Prostate Cancer Treatment and Research (3 papers) and Kidney Stones and Urolithiasis Treatments (2 papers). Lijun Yang collaborates with scholars based in China, United States and Japan. Lijun Yang's co-authors include Jianlin Yuan, Fuli Wang, Weijun Qin, Geng Zhang, Jun Li, Weijun Qin, Weihong Wen, Changhong Shi, Fa Yang and He Wang and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Lijun Yang

22 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lijun Yang China 10 109 94 82 81 58 25 350
Yütong Miao China 7 109 1.0× 96 1.0× 101 1.2× 48 0.6× 18 0.3× 9 331
Dong‐Chen Shieh Taiwan 8 107 1.0× 91 1.0× 97 1.2× 48 0.6× 68 1.2× 13 421
Cathy Gomila France 12 127 1.2× 33 0.4× 40 0.5× 56 0.7× 42 0.7× 22 312
Dajun Hu China 8 79 0.7× 90 1.0× 28 0.3× 48 0.6× 27 0.5× 18 327
Ha Thi Nga South Korea 8 120 1.1× 61 0.6× 71 0.9× 102 1.3× 23 0.4× 14 286
Zihao Li China 8 258 2.4× 63 0.7× 127 1.5× 33 0.4× 30 0.5× 14 407
Raffaele Capoano Italy 12 112 1.0× 196 2.1× 43 0.5× 40 0.5× 23 0.4× 25 379
Olga Bloch Israel 13 82 0.8× 107 1.1× 52 0.6× 34 0.4× 32 0.6× 24 331
Sabrina L. Jeter-Jones United States 10 247 2.3× 23 0.2× 52 0.6× 107 1.3× 89 1.5× 15 518
Shuai Zheng China 11 130 1.2× 40 0.4× 42 0.5× 31 0.4× 22 0.4× 14 342

Countries citing papers authored by Lijun Yang

Since Specialization
Citations

This map shows the geographic impact of Lijun Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijun Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijun Yang more than expected).

Fields of papers citing papers by Lijun Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lijun Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijun Yang. The network helps show where Lijun Yang may publish in the future.

Co-authorship network of co-authors of Lijun Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Lijun Yang. A scholar is included among the top collaborators of Lijun Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lijun Yang. Lijun Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Chang, Dan Du, Jie Yin, et al.. (2025). CircNF1 modulates the progression and immune evasion of esophageal squamous cell carcinoma through dual regulation of PD-L1. Cellular & Molecular Biology Letters. 30(1). 37–37. 5 indexed citations
2.
Jing, Yuming, Zhicheng Xu, Hongfan Zhao, et al.. (2025). The mechanism of histone modifications in regulating enzalutamide sensitivity in advanced prostate cancer. International Journal of Biological Sciences. 21(6). 2880–2890.
3.
Lu, Tong, Fanchao Wei, Xinglin He, et al.. (2025). The role of inflammation and ROS in CaOx kidney stones. European journal of medical research. 30(1). 1224–1224.
4.
Hu, Yaohua, Hui Li, Tong Lü, et al.. (2025). Inhibition of stromal MAOA leading activation of WNT5A enhance prostate cancer immunotherapy by involving the transition of cancer-associated fibroblasts. Journal for ImmunoTherapy of Cancer. 13(3). e010555–e010555. 7 indexed citations
5.
Zhang, Yao-Zhong, Qingqing Yang, Qi Peng, et al.. (2024). Impaired arginine/ornithine metabolism drives severe HFMD by promoting cytokine storm. Frontiers in Immunology. 15. 1407035–1407035. 3 indexed citations
7.
Lü, Tong, Jiayu Zhang, Shiqi Lu, et al.. (2023). Endosialin-positive tumor-derived pericytes promote tumor progression through impeding the infiltration of CD8+ T cells in clear cell renal cell carcinoma. Cancer Immunology Immunotherapy. 72(6). 1739–1750. 9 indexed citations
8.
Lu, Lu, et al.. (2023). Congenital candidiasis in a full-term infant: A case report. Journal of International Medical Research. 51(4). 3639218943–3639218943. 1 indexed citations
9.
Yu, Changjiang, Longlong Zhang, Fuli Wang, et al.. (2021). PHLDA3 exerts an antitumor function in prostate cancer by down-regulating Wnt/β-catenin pathway via inhibition of Akt. Biochemical and Biophysical Research Communications. 571. 66–73. 10 indexed citations
10.
Jiao, Jianhua, Jingliang Zhang, Weihong Wen, et al.. (2021). The Establishment of New Thresholds for PLND-Validated Clinical Nomograms to Predict Non-Regional Lymph Node Metastases: Using 68Ga-PSMA PET/CT as References. Frontiers in Oncology. 11. 658669–658669. 6 indexed citations
11.
Li, Yu, Keying Zhang, Fa Yang, et al.. (2021). Prognostic Value of Vascular-Expressed PSMA and CD248 in Urothelial Carcinoma of the Bladder. Frontiers in Oncology. 11. 771036–771036. 9 indexed citations
12.
Hou, Niuniu, Lijun Yang, Xiaojian Yang, et al.. (2021). The first competing risk survival nomogram in patients with papillary renal cell carcinoma. Scientific Reports. 11(1). 11835–11835. 6 indexed citations
13.
14.
Peng, Rong, Hailong Li, Lijun Yang, et al.. (2020). Immunonutrition for traumatic brain injury in children and adolescents: protocol for a systematic review and meta-analysis. BMJ Open. 10(9). e037014–e037014. 1 indexed citations
15.
Deng, Lingli, et al.. (2020). Magnetic resonance imaging for the non-invasive diagnosis in patients with ovarian cancer. Medicine. 99(50). e23551–e23551.
16.
Yang, Aijun, et al.. (2017). Effect of Qingfei Mixture (清肺合剂) on pediatric mycoplasma pneumoniae pneumonia with phlegm heat obstructing Fei (Lung) syndrome. Chinese Journal of Integrative Medicine. 23(9). 681–688. 6 indexed citations
17.
Wu, Guojun, et al.. (2017). Fragmentation of Severely Encrusted Ureteral Stent Indwelled for 4 Years in a Boy. Urology Case Reports. 12. 1–3. 7 indexed citations
18.
Yang, Lijun, Jianlin Yuan, Liwen Liu, et al.. (2013). α-linolenic acid inhibits human renal cell carcinoma cell proliferation through PPAR-γ activation and COX-2 inhibition. Oncology Letters. 6(1). 197–202. 39 indexed citations
19.
Wu, Guojun, Bo Zhang, Yang Gao, et al.. (2013). Effect of Early Adrenal Vein Ligation on Blood Pressure and Catecholeamine Fluctuation During Laparoscopic Adrenalectomy for Pheochromocytoma. Urology. 82(3). 606–611. 15 indexed citations
20.
Yao, Liping, Jianlin Yuan, Heliang Liu, et al.. (2009). Protective Effects of Inosine on Urinary Bladder Function in Rats With Partial Bladder Outlet Obstruction. Urology. 73(6). 1417–1422. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026